Early induction of cytokines/cytokine receptors and Cox2, and activation of NF-κB in 4-nitroquinoline 1-oxide-induced murine oral cancer model

Toxicology and Applied Pharmacology
Yu-Ching LiuJing-Gung Chung

Abstract

The purpose of this study was to identify the genes induced early in murine oral carcinogenesis. Murine tongue tumors induced by the carcinogen, 4-nitroquinoline 1-oxide (4-NQO), and paired non-tumor tissues were subjected to microarray analysis. Hierarchical clustering of upregulated genes in the tumor tissues revealed an association of induced genes with inflammation. Cytokines/cytokine receptors induced early were subsequently identified, clearly indicating their involvement in oral carcinogenesis. Hierarchical clustering also showed that cytokine-mediated inflammation was possibly linked with Mapk6. Cox2 exhibited the greatest extent (9-18 fold) of induction in the microarray data, and its early induction was observed in a 2h painting experiment by RT-PCR. MetaCore analysis showed that overexpressed Cox2 may interact with p53 and transcriptionally inhibit expression of several downstream genes. A painting experiment in transgenic mice also demonstrated that NF-κB activates early independently of Cox2 induction. MetaCore analysis revealed the most striking metabolic alterations in tumor tissues, especially in lipid metabolism resulting from the reduction of Pparα and Rxrg. Reduced expression of Mapk12 was noted, and MetaCore...Continue Reading

References

Nov 1, 1995·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Y C KoC C Tsai
Mar 31, 1998·Environmental Health Perspectives·J E KlaunigE F Walborg
Nov 7, 2000·The Journal of Biological Chemistry·G Q WangH Rabinowich
Jan 15, 2002·American Journal of Physiology. Cell Physiology·Martin G SchwachaIrshad H Chaudry
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiao-Han TangLorraine J Gudas
Jun 16, 2005·Molecular Cancer Therapeutics·Abhijit G BanerjeeJamboor K Vishwanatha
Nov 15, 2005·International Journal of Cancer. Journal International Du Cancer·Xiaoqin YangNaofumi Mukaida
Jun 17, 2006·Molecular Cancer Research : MCR·Zhongqiu ZhangMing You
Nov 13, 2008·International Journal of Cancer. Journal International Du Cancer·Jin Woo KimBao-Li Chang
Jan 8, 2009·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·N Y HsuH C Ho
May 26, 2009·Biochimica Et Biophysica Acta·Eun Mi ChoiJeong A Han
Jan 19, 2010·Breast Cancer Research : BCR·Jørgen AarøeAnne-Lise Børresen-Dale

❮ Previous
Next ❯

Citations

Jan 31, 2019·Oncogene·Carlos Rossa, Nisha J D'Silva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.